A Herpes Simplex Virus Type‐1‐Derived Influenza Vaccine Induces Balanced Adaptive Immune Responses and Protects Mice From Lethal Influenza Virus Challenge
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.70067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Paul J F Rider und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biotechnology and Molecular Medicine Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, B…. Hauptthemen laut MEDLINE: Influenza Vaccines, Adaptive Immunity, Antibodies, Viral, Orthomyxoviridae Infections. Die Arbeit nennt 53 Literaturangaben. Gefördert von: This research was supported by the National Institute of Allergy and Infectious Diseases., NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Influenza virus is a major respiratory viral pathogen responsible for the deaths of hundreds of thousands worldwide each year. Current vaccines provide protection primarily by inducing strain‐specific antibody responses with the requirement of a match between vaccine strains and circulating strains. It has been suggested that anti‐influenza T‐cell responses, in addition to antibody responses may provide the broadest protection against different flu strains. Therefore, to address this urgent need, it is desirable to develop a vaccine candidate with an ability to induce balanced adaptive immunity including cell mediated immune responses. Here, we explored the potential of VC2, a well‐characterized Herpes Simplex Virus type 1 vaccine vector, as a live attenuated influenza vaccine candidate. We generated a recombinant VC2 virus expressing the influenza A hemagglutinin protein. We show that this virus is capable of generating potent and specific anti‐influenza humoral and cell‐mediated immune responses. We further show that a single vaccination with the VC2‐derived influenza vaccine protects mice from lethal challenge with influenza virus. Our data support the continued development of VC2‐derived influenza vaccines for protection of human populations from both seasonal and pandemic strains of influenza. Finally, our results support the potential of VC2‐derived vaccines as a platform for the rapid development of vaccines against emerging and established pathogens, particularly respiratory pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biotechnology and Molecular Medicine Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA.
- Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA.
- Department of Microbiology and Plant Pathology, University of California, Riverside, California, USA.
- Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
ORCID-Profile: Konstantin G Kousoulas, Rong Hai
Förderung
- This research was supported by the National Institute of Allergy and Infectious Diseases.
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Rider, P. J. F., Dulin, H., Uche, I. K., McGee, M. C., Huang, W., Kousoulas, K. G., & Hai, R. (2024). A Herpes Simplex Virus Type‐1‐Derived Influenza Vaccine Induces Balanced Adaptive Immune Responses and Protects Mice From Lethal Influenza Virus Challenge. Journal of Medical Virology. https://doi.org/10.1002/jmv.70067
Vancouver
Rider PJF, Dulin H, Uche IK, McGee MC, Huang W, Kousoulas KG, et al. A Herpes Simplex Virus Type‐1‐Derived Influenza Vaccine Induces Balanced Adaptive Immune Responses and Protects Mice From Lethal Influenza Virus Challenge. Journal of Medical Virology. 2024. doi:10.1002/jmv.70067
BibTeX
@article{Rider2024,
author = {Rider, Paul J F and Dulin, Harrison and Uche, Ifeanyi K and McGee, Michael C and Huang, Weishan and Kousoulas, Konstantin G and Hai, Rong},
title = {A Herpes Simplex Virus Type‐1‐Derived Influenza Vaccine Induces Balanced Adaptive Immune Responses and Protects Mice From Lethal Influenza Virus Challenge},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.70067}
}
EUVIMED